JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Tcaciuc, Eugen | |
| dc.contributor.author | Ciuhrii, Veaceslav | |
| dc.contributor.author | Cornea, Natalia | |
| dc.contributor.author | Tofan, Valentin | |
| dc.date.accessioned | 2019-06-11T13:49:34Z | |
| dc.date.available | 2019-06-11T13:49:34Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | TCACIUC, Eugen; CIUHRII, Veaceslav; CORNEA, Natalia; TOFAN, Valentin. Tratamentul cu Imupurin şi Imuheptin al pacienţilor cu ciroză hepatică de etiologie. In: Sănătate Publică, Economie şi Management în Medicină. 2017, nr. 3(73), pp. 177-179. ISSN 1729-8687. | en_US |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/1476 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/04/cm3_73_2017cg-2.pdf | |
| dc.description | IPUSMF Nicolae Testemițanu, Departamentul Medicină Internă, Newtone Laboratories | en_US |
| dc.description.abstract | Assessment of the evolution of clinical, biochemical and immunological parameters in patients with liver cirrhosis under the influence of treatment with Imuheptin and Imupurin was the purpose of this study. After 3 months of treatment was found complete regression or decrease of clinical signs and syndroms: dyspepsic and astenovegetativ syndroms. The results of laboratory investigations confirmed the positive evolution of clinical signs. Decrease of ALT activity in all monitored patients were found and decrease of CIC. During the study all patients established good tolerability of the administered medication. | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească "Economie, Management și Psihologie în Medicină" din Republica Moldova | en_US |
| dc.relation.ispartof | Sănătate Publică, Economie şi Management în Medicină: Al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova | |
| dc.subject.ddc | CZU 616.36-004-022.7:578.89+615.37 | |
| dc.subject.mesh | Liver Cirrhosis--etiology | en_US |
| dc.subject.mesh | Liver Cirrhosis--drug therapy | en_US |
| dc.subject.mesh | Imucheptin--therapeutic use | en_US |
| dc.subject.mesh | Imupurin--therapeutic use | en_US |
| dc.title | Tratamentul cu Imupurin şi Imuheptin al pacienţilor cu ciroză hepatică de etiologie | en_US |
| dc.title.alternative | Treatment with Imupurin and Imuheptin of patients with hepatic cirrhosis of viral ethiology | en_US |
| dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
-
Sănătate Publică, Economie şi Management în Medicină Nr. 3 (73) / 2017
Materialele celui de al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova